On October 1, 2024, Frank Corvino, former Director of HealthEquity Inc (HQY, Financial), sold 1,247 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 4,823 shares of HealthEquity Inc.
HealthEquity Inc specializes in providing technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Their services include health savings accounts, health reimbursement arrangements, and other financial healthcare services.
Over the past year, Frank Corvino has sold a total of 8,952 shares and has not made any purchases of the company's stock. This recent sale is part of a broader trend within HealthEquity Inc, where there have been 19 insider sells and no insider buys over the past year.
Shares of HealthEquity Inc were trading at $80.26 on the day of the sale. The company has a market cap of approximately $6.827 billion. The price-earnings ratio of the stock stands at 65.15, which is above the industry median of 23.815.
The stock's GF Value is estimated at $82.57, indicating a price-to-GF-Value ratio of 0.97. This suggests that HealthEquity Inc is Fairly Valued based on its GF Value.
The GF Value is calculated considering historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This sale by a former director continues the trend of insider selling at HealthEquity Inc, providing investors with insights into the recent activities of company insiders.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
